Zobrazeno 1 - 10
of 11 366
pro vyhledávání: ''
Publikováno v:
BMJ case reports. 14(7)
We report a case of vancomycin-induced thrombocytopenia (VIT) with rapid onset after re-exposure to vancomycin. A 58-year-old man with cellulitis was initiated on vancomycin. Approximately 1 hour into the vancomycin infusion, the patient developed an
Publikováno v:
BMJ Case Rep
Statin-induced necrotising autoimmune myopathy (SINAM), a rare complication of statin use, presents with significant proximal muscle weakness and raised creatine kinase (CK) levels (50–100 times). This is different from other musculoskeletal condit
Autor:
José Antonio Rueda-Camino, Celia Zamarro-García, María Angelina-García, Vanesa Sendín-Martín, Francisco Javier Gimena-Rodríguez, Raquel Barba-Martín, María Dolores Joya-Seijo
Publikováno v:
Medicina Clinica
D-dimer levels are elevated in COVID 19 and they correlate to the levels of other inflammatory markers such us ferritin, fibrinogen and C-reactive protein. It may be possible to correct D-dimer value in function of inflammatory markers, thus identify
Autor:
Hugh Wright, Angus Lane
Publikováno v:
BMJ Case Rep
Echinococcosis or human hydatid disease is a helminthic infection is caused by Echinococcus species. Classically, cystic echinococcosis is caused by Echinococcus granulosus sensu stricto, E. equinus, E. ortleppi and E. canadensis, though several othe
Autor:
Lev Lichtenstein, Eran Maoz, Sophy Goren, Adva Levy-Barda, Eyal Shachar, Maya Aharoni Golan, Michal Navon, Maor H. Pauker, Baruch Ovadia, Natalia T. Freund, Arie Segal, Hadar Edelman-Klapper, Rami Eliakim, Joel Alter, Jacob E. Ollech, Hagar Banai-Eran, Keren M. Rabinowitz, Haim Ben Zvi, Revital Barkan, Michal Werbner, Idan Goren, Ariella Bar-Gil Shitrit, Yelena Broitman, Henit Yanai, Tsachi-Tsadok Perets, Yifat Snir, Noy Krugliak, Shomron Ben-Horin, Dani Cohen, Meital Gal-Tanamy, Adi Friedenberg, Irit Avni-Biron, Moshe Dessau, Iris Dotan, Eran Zittan
Publikováno v:
Gastroenterology
Background Patients with inflammatory bowel diseases (IBD), specifically those treated with anti-tumor-necrosis-factor (TNF)α biologics are at high risk for vaccine preventable infections. Their ability to mount adequate vaccine responses is unclear
Autor:
Zhihua Tao, Pan Yu, Lingyu Zhang, Ying Cao, Tao Sun, Xuchu Wang, Danhua Wang, Yan Chen, Zhenping Liu, Yibei Dai, Ying Ping, Wen Hu, Qiao Yu, Yiwen Sang
Publikováno v:
Clinical Biochemistry. 100:35-41
BACKGROUND Although endoscopy is the gold standard to assess disease activity and infliximab efficacy in inflammatory bowel disease (IBD), the invasive, costly, and time-consuming procedure limits its routine applications. We aimed to investigate the
Autor:
Christopher L Julien, Sridevi Devaraj, Claire E. Bocchini, Joseph A. Spinner, Lily Olayinka, Flor M. Munoz, William J. Dreyer
Publikováno v:
The Journal of Heart and Lung Transplantation
BACKGROUND: There is a paucity of data regarding the antibody response to SARS-CoV-2 vaccination in children after solid organ transplant.We retrospectively reviewed the SARS-CoV-2 Anti-Spike IgG antibodies measured following SARS-CoV-2 vaccination a
Autor:
Hidekazu Tachibana, Kazunari Tanabe, Hiroki Ishihara, Toshio Takagi, Kazuhiko Yoshida, Yuki Nemoto, Junpei Iizuka, Hironori Fukuda, Tsunenori Kondo, Yasunobu Hashimoto
Publikováno v:
Clinical Genitourinary Cancer. 20:e81-e88
Serum C-reactive protein (CRP) is reportedly associated with metastatic renal cell carcinoma (mRCC) activity. However, in the era of immune checkpoint inhibitors, the predictive value of CRP is unclear. In this study, we investigated the predictive i
Autor:
Emina Sudar-Milovanovic, Esma R. Isenovic, Dragan Stajic, Milan Obradovic, Bojan Mitrovic, Djuro Macut, Zoran Gluvic, Sanja Soskic
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 22:117-124
Background and Objectives : Non-alcoholic fatty liver disease (NAFLD) is associated with inflammation and subsequent increase in cardiovascular risk. Because of its widespread presence and distribution, invasive diagnostic procedures (i.e., liver bio
Autor:
Hiroyuki Motoyama, Norifumi Kawada, Kohei Kotani, Akihiro Tamori, Naoshi Odagiri, Hideki Fujii, Hoang Hai, Le Thi Thanh Thuy, Atsushi Hagihara, Minh Phuong Dong, Masaru Enomoto, Ritsuzo Kozuka, Etsushi Kawamura, Sawako Uchida-Kobayashi, Kanako Yoshida
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Scientific Reports
Scientific Reports
Soluble immune checkpoint molecules are emerging novel mediators of immune regulation. However, it is unclear whether soluble immune checkpoint proteins affect the development of hepatocellular carcinoma (HCC) during nucleos(t)ide analogue (NA) treat